Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Triptonide is a natural small molecule derived from *Tripterygium wilfordii* ("Thunder God Vine"), a plant long used in traditional Chinese medicine. Triptonide is classified as a diterpene triepoxide with potent pharmacological activity, notably as a **non-hormonal, reversible male contraceptive** and as a potential antitumor agent[1][3][5][7]. It acts by interfering with the final steps of sperm assembly, leading to sperm deformation and severely reduced motility, without affecting hormonal levels (FSH, LH, testosterone) or causing major organ toxicity in animal models[1][2]. Triptonide also exhibits anti-cancer, anti-diabetic, anti-obesity, and anti-inflammatory effects in preclinical studies[3][5]. Its toxicity profile is markedly safer than similar compounds such as triptolide[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on triptonide.